Global Market Size of Biosimilars Market – 10 Year Market Forecast

Pharmaceuticals

Biosimilars Market Size Forecast 2022-2029

A biosimilar is a biological product that are very similar copies of biologic drugs that are manufactured by a different company. Government-approved biosimilars are used as treatments for conditions such as psoriasis, psoriatic arthritis, diabetes, Crohn’s disease etc. Over the study period, APAC is expected to dominate the market by accounting for the largest shares and generating the highest market revenues. The biosimilars market trends indicate the market size to grow from USD 42.14 billion in 2022 up to a projected market value of USD 122.23 billion by 2029, with a growth rate (CAGR) of 16%. According to the calculations, the cumulative market size should be USD 654 billion.

Frequently Asked Questions(FAQ)

• What is Global Market Database?

• Global market database studies the ongoing trends within the market and updates the market information on a quarterly basis.
• What are biosimilars?

• A biosimilar is a biological product that are very similar copies of biologic drugs that is manufactured by a different company.
• What are biosimilars used for?

• Biosimilars are used as treatments for conditions such as psoriasis, psoriatic arthritis, diabetes, Crohn's disease etc.
• What are the two manufacturing types of biosimilars?

• The two manufacturing types of biosimilars are in-house manufacturing and contract manufacturing.
• Which biosimilar products have been considered in this report?

• The biosimilar products considered in this report are recombinant glycoslated protein, recombinant non-glycoslated proteins and recombinant peptides.

Related Markets

• Global Market Size of Vitamin D Therapy Market – 10 Year Market Forecast
• Global Market Size of Parkinson’s Disease Treatment Market – 10 Year Market Forecast
• Global Market Size of Cardiac Safety Services Market – 10 Year Market Forecast
• Global Market Size of Cell Counting Market – 10 Year Market Forecast
• Global Market Size of Clinical Trial Imaging – 10 Year Market Forecast